NDC 0169-3004
Novolin N
Human Insulin
Novolin N is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Human.
| Product ID | 0169-3004_1340b9b9-04ce-4c26-b7d0-b098bd82c65a |
| NDC | 0169-3004 |
| Product Type | Human Otc Drug |
| Proprietary Name | Novolin N |
| Generic Name | Human Insulin |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2019-09-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019959 |
| Labeler Name | Novo Nordisk |
| Substance Name | INSULIN HUMAN |
| Active Ingredient Strength | 100 [iU]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 0169-3004-15
5 SYRINGE, PLASTIC in 1 CARTON (0169-3004-15) > 3 mL in 1 SYRINGE, PLASTIC (0169-3004-01)
| Marketing Start Date | 2019-09-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0169-3004-15 [00169300415]
Novolin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA019959 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-09-06 |
NDC 0169-3004-01 [00169300401]
Novolin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA019959 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-09-06 |
NDC 0169-3004-25 [00169300425]
Novolin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA019959 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-09-06 |
NDC 0169-3004-12 [00169300412]
Novolin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA019959 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-09-06 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| INSULIN HUMAN | 100 [iU]/mL |
NDC Crossover Matching brand name "Novolin N" or generic name "Human Insulin"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0169-1833 | Novolin | Human Insulin |
| 0169-1834 | Novolin | Human Insulin |
| 0169-1837 | Novolin | Human Insulin |
| 0169-3003 | Novolin | Human Insulin |
| 0169-3004 | Novolin | Human Insulin |
| 0169-3007 | Novolin | Human Insulin |
| 50090-0403 | Novolin | Human Insulin |
| 50090-0497 | Novolin | Human Insulin |
| 50090-0498 | Novolin | Human Insulin |
| 64725-1833 | Novolin | Human Insulin |
| 64725-1834 | Novolin | Human Insulin |
| 64725-1837 | Novolin | Human Insulin |
| 68071-1701 | Novolin | Human Insulin |
Trademark Results [Novolin]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NOVOLIN 73498651 1384926 Live/Registered |
NOVO INDUSTRI A/S 1984-09-10 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.